DR. ARATI MALLIK DUNBAR, M.D.

Plain English
This study looked at food insecurity, which means not having enough access to nutritious food, among kids admitted to two different hospital areas: the Pediatric Intensive Care Unit (PICU) and the general hospital ward. They found that 9% of the kids in the PICU were food insecure, compared to 6.5% in the general ward. It’s particularly concerning that food insecurity was more common in Black (240% more likely) and Hispanic kids (544% more likely) compared to White kids. Who this helps: This research benefits pediatric patients and healthcare providers by highlighting the need for better support systems in hospitals.

Plain English
This study looked at a rare condition called Rapunzel syndrome in a 10-year-old girl who had difficulties with eating and was also diagnosed with attention-deficit hyperactivity disorder (ADHD). The girl experienced significant weight loss and stomach pain, and doctors eventually found a large hairball in her stomach that extended into her intestines, which was successfully removed through surgery. This finding is important because it shows that serious issues like Rapunzel syndrome can be mistaken for common feeding problems, and using MRI scans can help diagnose such cases without exposing young patients to radiation. Who this helps: This helps patients with sensory feeding difficulties and their doctors by improving diagnosis and treatment options.

Plain English
Researchers studied the challenges dietitians face when providing timely nutrition support to patients with gastrointestinal cancers, finding that 61% of these patients experience malnutrition. They identified five main barriers: access to care, timing of referrals, lack of coordination among teams, workforce shortages, and the emotional strain on dietitians. Addressing these issues is important because improving nutrition support can significantly enhance patient outcomes, including better treatment tolerance and overall health. Who this helps: This helps patients with gastrointestinal cancers and the dietitians who care for them.

Plain English
Researchers studied a new drug called Nezavist as a potential treatment for alcohol use disorder (AUD), which affects about 28.9 million people in the U.S. Each year. Their findings showed that Nezavist significantly reduced the chance of relapse in animals that were dependent on alcohol, suggesting that it may help decrease cravings by acting on the gut to send signals to the brain. This matters because there are currently very few effective medications for AUD, and Nezavist could lead to better treatment options for those struggling with this disorder. Who this helps: This helps patients with alcohol use disorder and their healthcare providers.

Plain English
This study looked at the effects of a drug called SY-5609, which inhibits CDK7, on a type of blood cancer called secondary acute myeloid leukemia (sAML) that can develop from myeloproliferative neoplasms (MPNs). The researchers found that SY-5609 effectively killed specific cancer cells while leaving healthy cells alone, showing promising results in lab tests and mouse models. Combining SY-5609 with other treatments increased its effectiveness, leading to reduced cancer burden and improved survival rates without harming normal cells. Who this helps: This research benefits patients with advanced myeloproliferative neoplasms and their doctors by offering new treatment options.

Plain English
This study looked at how different intensities of exercise affect a type of immune cell called T cells. Researchers found that after high-intensity exercise, T cells multiplied more than after moderate-intensity exercise, with a significant increase that lasted for up to 6 hours. This matters because it shows that intense workouts can boost the immune system's readiness to respond to infections or other challenges. Who this helps: This helps patients looking to strengthen their immune response and health.

Plain English
This research looks at how telehealth can help people with Borderline Personality Disorder (BPD) in rural areas access Dialectical Behaviour Therapy (DBT), which is a proven treatment. It highlights that many people in these regions struggle to find proper mental health care and suggests using a combination of telehealth services and community-based support to provide DBT. The findings show that this approach could significantly increase the availability of effective therapy for those in need. Who this helps: This benefits patients with BPD living in rural areas.

Plain English
This study looked at how the location of myelomeningocele (MMC) in the spine affects brain development and the need for managing fluid buildup in the brain (hydrocephalus) after surgery. Researchers found that patients with higher-level MMC (L1-L3) had larger brain ventricles and a 32% higher likelihood of needing fluid management after surgery compared to those with lower-level MMC (L4-sacrum). This shows that higher MMC levels may lead to more brain changes and complications if surgery occurs after birth, highlighting the advantage of prenatal repair options. Who this helps: This research benefits doctors, parents of MMC patients, and healthcare teams involved in prenatal treatment options.

Plain English
This research looked at how an experimental drug called tasquinimod (TQ) works against advanced myeloproliferative neoplasms (MPNs) when tested on both cell lines and patient-derived cells. The findings showed that TQ reduced the survival of MPN cells while sparing normal blood cell progenitors, and when combined with other drugs like ruxolitinib, it significantly improved outcomes in lab-grown models. These results are important because they suggest that TQ could enhance current treatment options for patients with aggressive forms of MPN. Who this helps: This helps patients with advanced myeloproliferative neoplasms.

Plain English
This study looked at two patients with a rare type of cancer called liposarcoma that occurred in the spermatic cord, which connects the testicles to the body. Both patients were initially misdiagnosed, leading to delays in their treatment, highlighting the need for better awareness among doctors since these tumors can be confused with more common issues like cysts or hernias. Understanding these cases is important because it can improve the diagnosis and management of similar patients in the future. Who this helps: This helps doctors and patients who may be facing misdiagnoses and delays in treatment for rare tumors.

Plain English
This study examined how the body processes two antiviral drugs, sofosbuvir and velpatasvir, used to treat hepatitis C in pregnant women. Researchers found that, during pregnancy, the level of sofosbuvir in the body was significantly higher—60% more overall and 49% more at its peak—compared to non-pregnant women, while a byproduct of the drug was lower by 43%. Both the safety and tolerability of these medications were confirmed, which is important for ensuring effective treatment for hepatitis C in pregnant women and their babies. Who this helps: This helps pregnant women with hepatitis C and their healthcare providers.

Plain English
This study looked at how birds that eat feces (a behavior called coprophagy) might influence their gut bacteria. The researchers found that this behavior could help young birds establish important gut bacteria, provide needed nutrients, and help birds adapt to changing diets, but it could also expose them to harmful chemicals and germs. Understanding these effects is important because it can impact bird health and survival in different environments. Who this helps: This research helps conservationists and wildlife biologists understand bird health and adapt strategies for protecting bird populations.

Plain English
This study explored how certain nanoparticles can help brain cells called microglia recover after spinal cord injuries. Researchers found that when they introduced these nanoparticles, the microglia changed shape and increased their production of healing signals, while reducing harmful inflammation. Specifically, the treated cells showed higher levels of anti-inflammatory markers like Arginase-1 and CD206, indicating a shift towards a healing state without increasing pro-inflammatory signals. Who this helps: This benefits patients with spinal cord injuries by potentially improving recovery outcomes.

Plain English
This study looked at how a specific signaling pathway, called Hedgehog signaling, affects blood cell growth and fibrosis in certain blood cancers known as myeloproliferative neoplasms (MPNs). The researchers found that higher levels of a protein called Gli1 in patients’ blood cells are linked to worsening fibrosis, and that removing Gli1 in lab models reduced cancer symptoms and fibrosis. These findings suggest that targeting Gli1 could be an effective treatment for MPNs, as it plays a key role in the disease without impacting normal blood cell production. Who this helps: This benefits patients with myeloproliferative neoplasms.

Plain English
This study examined the differences in brain development between newborns who had surgery for a condition called myelomeningocele (MMC) before birth and those who had surgery afterward. Researchers found that only 24% of babies who had prenatal surgery needed additional procedures to manage fluid buildup, compared to 67% of those who had postnatal surgery. Additionally, abnormalities in brain structure were less common in those who had prenatal surgery, suggesting that operating before birth may lead to better neurological outcomes. Who this helps: This helps patients with myelomeningocele and their families by providing important information about treatment options.

Plain English
Researchers studied the effects of special nanoparticles made with a carbohydrate called α-gal on healing after spinal cord injuries in mice. They found that mice treated with α-gal nanoparticles showed better recovery, including more healing in their nerves and stronger movements, compared to those given a control treatment. Specifically, the treated mice had more anti-inflammatory cells at the injury site and improved motor skills, making the data promising for future treatments in spinal cord injuries. Who this helps: This helps patients with spinal cord injuries.

Plain English
Researchers looked at the role of a specific inflammatory protein, IL-1β, in the development of atherosclerosis, which is a condition that can lead to heart disease. They found that when IL-1β was suppressed, there was an increase in beneficial cells called fibroblast-like cells in the plaques found in arteries, which helped stabilize these plaques. This is important because stable plaques are less likely to cause serious heart problems, potentially reducing the risk of heart attacks. Who this helps: This study benefits patients at risk for heart disease.

Plain English
This study looked at how head size develops in children with myelomeningocele (MMC) who had surgery before or after birth. Researchers found that children who had prenatal surgery had larger head sizes than those who had postnatal surgery. Specifically, the prenatal group had a head circumference that was higher than average, and those with larger head sizes were more likely to need further treatment for hydrocephalus, with a relative risk of 10.0 for the prenatal group. Who this helps: This information benefits doctors and caregivers of children with MMC, helping them make informed decisions about treatment options.

Plain English
This study looked at children with a spinal defect called myelomeningocele (MMC) and how they develop hydrocephalus (a build-up of fluid in the brain) based on whether they had surgery before or after birth. Researchers found that 40% to 85% of these children still develop hydrocephalus, with some specific indicators like head growth rate in the first 90 days being key predictors. They discovered that children who had surgery before birth were more likely to develop hydrocephalus after three months compared to those who had surgery after birth, despite overall lower rates of hydrocephalus in the prenatal group. Who this helps: This research helps doctors and families of children with MMC by providing insights into when to monitor for hydrocephalus after surgery.

Plain English
This study focused on improving the obstetric (OB) skills of hospital staff in rural areas where maternity care is limited. By using a mobile training program, they found that 98% of trainers felt more confident in implementing simulations, and hospital staff reported a 30% increase in their ability to handle postpartum hemorrhage (a serious bleeding complication after childbirth). This matters because better training can lead to safer care for mothers in areas with fewer resources. Who this helps: This helps patients in rural areas who need maternity care.

Plain English
This study looked at a new way to improve CAR T cell therapy for patients with acute myeloid leukemia (AML) by targeting a specific part of the CD33 protein, called the membrane-proximal domain. Researchers developed a new CAR T cell called 3P14HLh28Z, which outperformed existing treatments by showing better activity against tumors, improving patient survival rates, and working effectively even when there were fewer target proteins available on cancer cells. This is important because it highlights a new approach that could lead to more effective treatments for AML patients, especially those with lower levels of the CD33 target. Who this helps: Patients with acute myeloid leukemia (AML).

Plain English
This study looked at systemic mastocytosis, a condition where mast cells (a type of immune cell) build up in the body and cause various symptoms. The researchers found that patients benefit from being treated at specialized centers with experts who work together on different aspects of care; for example, allergists help manage allergic reactions and anesthesiologists assist with surgery. These updated guidelines aim to improve diagnosis and treatment options for patients with systemic mastocytosis. Who this helps: This helps patients with systemic mastocytosis and their healthcare providers.

Plain English
This study looked at how certain genetic changes in patients with acute myeloid leukemia (AML) can help predict their chances of clearing measurable residual disease (MRD) after treatment. Among 211 patients, 35% achieved complete MRD clearance after initial chemotherapy, while 27% showed some disease but were considered in remission, and 38% still had persistent disease. The findings revealed that patients with mutations like CEBPA or NPM1 were more likely to clear MRD, while those with TP53 mutations were less likely. Who this helps: This research benefits doctors and patients with AML by providing insights into the genetic factors influencing treatment outcomes.

Plain English
This study looked at how a special test called a polymerase chain reaction (PCR) can help identify resistance to antifungal medication in patients with a serious lung infection caused by the fungus Aspergillus fumigatus. Out of 323 patients, 36% had invasive aspergillosis, and the test showed that 14% of those with a specific type of resistance had treatment failures. This finding is important because early detection of resistance can lead to more effective treatment and potentially save lives. Who this helps: This helps patients with invasive aspergillosis and their doctors.

Plain English
This study looked at a new test for diagnosing a serious lung infection called invasive pulmonary aspergillosis (IPA) in patients with blood disorders. Researchers analyzed 141 fluid samples from the lungs, finding that 47% of the patients had probable IPA. The new automated test (CLIA) showed similar accuracy to the traditional test (EIA) but provides results faster, which could improve patient care. Who this helps: Patients with blood disorders who are at risk for lung infections.

Plain English
This study looked at how specific genetic mutations related to myelodysplasia (a type of blood disorder) affect the prognosis of patients with acute myeloid leukemia (AML). Researchers examined 344 patients and found that these mutations are often present in newly diagnosed AML patients, but they do not necessarily lead to worse outcomes. Specifically, only mutations in the EZH2 and SF3B1 genes were linked to poorer survival rates, but overall, the patient's medical history (ontogeny) was a more reliable indicator of their prognosis. Who this helps: This research helps doctors make better predictions about treatment outcomes for patients with AML.

Plain English
This study looked at how men felt after undergoing surgeries to treat stress urinary incontinence. Out of 41 patients surveyed, the average level of regret about their decision was 29.78 on a scale of 0 to 100, with most experiencing little to no regret. Factors like having previous pelvic radiation and the type of surgery contributed to higher regret levels. Who this helps: This helps patients and doctors by highlighting the importance of personalized treatment choices and discussions before surgery.

Plain English
This study looked at how a property called spillover energy can help design better catalysts, specifically single-atom alloys (SAAs), for breaking down formic acid. The researchers found that a nickel-copper alloy (NiCu) was effective because it made the formate intermediates more stable at nickel sites, leading to improved reactivity compared to just copper. Although using NiCu particles showed only a slight improvement in a practical test, it still proves that spillover energy can be a valuable tool in designing more efficient catalysts. Who this helps: This benefits researchers and engineers working on catalyst technologies for chemical reactions.

Plain English
This study focused on understanding congenital hydrocephalus, a condition in which children's brains swell due to fluid buildup. Researchers analyzed genetic information from 483 patients and discovered that a gene called TRIM71 is crucial for proper brain cell development. When this gene is mutated, it leads to an improper formation of brain cells, resulting in hydrocephalus and changes in brain structure that do not involve the fluid flow but rather the cells themselves. Who this helps: This helps patients with congenital hydrocephalus and their doctors by providing insights for better treatment options.

Plain English
Researchers studied how a drug called Reparixin affects a condition known as myelofibrosis in mice. They found that mice treated with Reparixin showed less fibrosis in their bone marrow and spleen, and the amount of fibrosis decreased as the levels of Reparixin in the blood increased. This is important because it suggests that Reparixin could help improve the condition of people with myelofibrosis. Who this helps: This benefits patients with myelofibrosis and their doctors.

Plain English
This research studied how to improve the skills of doctors who deliver babies in rural hospitals, where they face unique challenges compared to those in cities. The study found that using mobile simulation training can effectively teach these doctors how to handle rare but dangerous situations, while also being cost-efficient. This matters because it ensures that rural healthcare providers can maintain their skills and provide safe care to mothers and babies. Who this helps: This helps rural obstetric providers and ultimately the patients they care for.

Plain English
This study focused on a home-visitation support program called Cradle to Kinder, aimed at helping disadvantaged families in Victoria, Australia. Researchers interviewed 37 people involved in the program and found that successful implementation depended on strong engagement with families, a supportive organizational culture, and clear benefits of the program. However, they also noted challenges, such as external pressures and differing expectations from other organizations. Who this helps: This benefits families at risk of child removal and the professionals supporting them.

Plain English
This study looked at a group of blood disorders called myeloproliferative neoplasms (MPNs), which include myelofibrosis, polycythemia vera, and essential thrombocythemia. Researchers developed guidelines to help doctors manage these conditions effectively, covering diagnosis, treatment options, and how to support patients throughout their treatment. These guidelines stress the importance of tracking patients' symptoms from the start and adjusting care as needed, ensuring better management and care for those affected by MPNs. Who this helps: This benefits patients with myeloproliferative neoplasms and their doctors.

Plain English
This study looked at how specific genetic changes in tumors might affect the risk of blood clots in cancer patients. Researchers found that certain mutations, especially in genes like STK11 and KRAS, can significantly increase the risk of blood clots by 34% to over 100% in patients with solid tumors. This is important because it helps doctors identify which patients might be more vulnerable to these dangerous complications, allowing for better monitoring and treatment. Who this helps: This benefits cancer patients and their healthcare providers.

Plain English
This study looks at how genetic changes in certain proteins affect blood cancers called myeloproliferative neoplasms (MPNs). The researchers found that mutations in these proteins can work together with other factors to make the disease worse. They also highlighted new treatments that target these genetic changes, which can help slow down the progression of the disease. Who this helps: Patients with myeloproliferative neoplasms.

Plain English
This study looked at how long patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) should receive antibiotics after developing febrile neutropenia (FN) during chemotherapy. Researchers compared two hospitals: one stopped antibiotics after 3 days unless there was an infection (Erasmus University Medical Center), while the other continued treatment until patients’ immune systems recovered (University Hospitals Leuven). They found that 12.5% of patients on the 3-day plan faced serious medical complications compared to 8.9% on the longer plan, showing that stopping antibiotics early is likely safe and can reduce unnecessary antibiotic use. Who this helps: This benefits patients undergoing chemotherapy by minimizing antibiotic exposure.

Plain English
Researchers studied how muscle changes as people age or deal with chronic illnesses, focusing on a condition called sarcopenia, which leads to reduced muscle mass and strength. They identified specific markers related to muscle aging and discovered differences in gene expression that impact muscle function; in the experiments, they found that these changes in gene splicing, which affect how muscles contract, occur in aging and conditions like myotonic dystrophy type 1. These findings are important because they enhance our understanding of muscle decline and could inform treatments to help maintain muscle health in older adults and those with chronic diseases. Who this helps: This helps patients suffering from sarcopenia and myotonic dystrophy, as well as their caregivers and healthcare providers.

Plain English
This research studied a rare condition called moyamoya disease (MMD), which causes narrowing of blood vessels in the brain and can lead to strokes, particularly in children. The researchers focused on the genetic causes of this disease in non-East Asian patients and found that about 12.5% of cases in their small discovery group carried harmful variants in a gene called DIAPH1. These discoveries are important because they help identify new genetic factors that could affect diagnosis and treatment for MMD. Who this helps: This helps patients with moyamoya disease and their doctors by providing insights into potential genetic causes and treatment options.

Plain English
This study looked at how common a serious infection called COVID-19-associated pulmonary aspergillosis (CAPA) is in patients in intensive care units. Researchers found that between 10% and 15% of 823 patients developed CAPA, and the death rates for those with this condition were alarmingly high, ranging from 43% to 52%. Understanding the risks and outcomes of CAPA is crucial for better treatment and care of COVID-19 patients. Who this helps: This helps doctors and healthcare providers treating critically ill COVID-19 patients.

Plain English
This study looked at a program in Victoria, Australia, designed to help families stay together and prevent children from being taken into foster care. It involved evaluating how well the program improved parenting skills, family safety, child development, and connection to services. If successful, these changes could lead to a significant reduction in the number of children entering foster care and promote better family environments. Who this helps: This benefits vulnerable families and their children.

Plain English
This study created a new way to build tiny, 3D models of human skeletal muscle using a gel-like material. The researchers found that when they electrically stimulated these muscle models for 3 hours, they showed signs of muscle growth and responded to treatments like caffeine that increased muscle force. This is important because it helps develop better medications for muscle wasting diseases. Who this helps: Patients with muscle wasting diseases.

Plain English
Researchers studied the presence of genetic mutations in specific blood cells from patients with Primary Myelofibrosis (PMF), a type of blood cancer. They found that 70% of the patients had at least one shared mutation in both the hematopoietic (blood-forming) cells and the circulating endothelial cells (which line blood vessels). This finding suggests that these endothelial cells play an important role in the disease and could lead to new ways to understand and treat PMF. Who this helps: This helps patients with Primary Myelofibrosis and their doctors.

Plain English
This study looked at pneumonia caused by a specific fungus (PCP) in patients with weakened immune systems, especially focusing on whether they received preventive treatment before getting sick. Out of 204 patients tested, 90 had probable PCP, and 74% of these patients did not have HIV. Alarmingly, only 7% had received the recommended preventive treatment, even though it was deemed necessary in 87% of cases. Who this helps: This helps immunocompromised patients who are at risk for pneumonia, including those without HIV.

Plain English
This study focused on a group of blood disorders known as myeloid/lymphoid neoplasms that involve a high number of eosinophils, a type of white blood cell. Researchers identified specific gene changes called fusion genes, which are linked to these disorders and created new guidelines for how to diagnose and treat them. The guidelines aim to improve patient care by outlining the steps for recognizing and managing these conditions, including specifics about genetic testing and treatment options. Who this helps: This helps patients with eosinophilic disorders and their doctors by providing clear guidance on diagnosis and treatment.

Plain English
Research focused on congenital hydrocephalus (CH), a condition where fluid builds up in the brain, causing the ventricles to enlarge. The study analyzed the genes of 381 patients and found that harmful genetic mutations are responsible for over 17% of cases, indicating that issues with early brain development are a key cause of CH rather than just problems with fluid drainage. Understanding these genetic factors may lead to better treatments and outcomes for affected individuals. Who this helps: Patients with congenital hydrocephalus and their families.

Plain English
Researchers studied trigeminal neuralgia (TN), a painful condition affecting the face that often does not respond to treatment, and found that genetic changes in certain brain signaling and ion transport proteins are linked to this disease. They analyzed the DNA of 290 people with TN and identified harmful genetic variants related to GABA receptors and calcium channels. This understanding could lead to better treatments for TN, as it highlights potential genetic causes of the condition. Who this helps: This helps patients suffering from trigeminal neuralgia.

Plain English
This study looked at how patients with chronic lymphocytic leukemia (CLL) treated with Bruton's tyrosine kinase (BTK) inhibitors, specifically ibrutinib, are at risk for serious invasive fungal infections (IFIs). The researchers found that two patients developed these infections while on treatment, highlighting how rare but severe these cases can be. Understanding this risk is important as it can help doctors monitor and manage infections better in CLL patients undergoing BTK inhibitor therapy. Who this helps: This helps patients with CLL and their doctors.

Plain English
This study looked at a new test to quickly diagnose a serious lung infection called invasive pulmonary aspergillosis (IPA) in patients in intensive care units (ICUs). Researchers tested the Aspergillus lateral flow assay on samples from 178 ICU patients and found that it accurately identified the infection in 88-94% of real cases, with a specificity of 81%. This is important because quicker diagnosis can lead to faster treatment, which is crucial for improving patient outcomes. Who this helps: This helps ICU patients at risk of lung infections.